Related Experiment Videos
Identification of protein kinase C phosphorylation sites in the angiotensin II (AT1A) receptor
1Molecular Endocrinology Laboratory, Baker Medical Research Institute, PO Box 6492, St. Kilda Road Central, Melbourne, Victoria 8008, Australia.
Abstract:
Protein kinase C (PKC) phosphorylates the C-terminus of the type 1 angiotensin II receptor (AT(1)), although the exact site(s) of phosphorylation are unidentified. In the present study, we examined the phosphorylation of epitope-tagged wild-type AT(1A) receptors, transiently expressed in Chinese hamster ovary K1 cells, in response to angiotensin II (AngII) and following selective activation and inhibition of PKC. This phosphorylation was compared with mutant receptors where C-terminal serine residues (Ser(331), Ser(338) and Ser(348)) within three putative PKC consensus sites were replaced with alanine, either individually or in combination. Stimulation by AngII or the phorbol ester PMA to activate PKC induced an increase in phosphorylation of the wild-type AT(1A) receptor, which was prevented by truncation of the receptor C-terminus to remove the last 34 amino acids, including Ser(331), Ser(338) and Ser(348). Whereas single alanine mutation (Ser(331)Ala, Ser(338)Ala and Ser(348)Ala) resulted in decreased receptor phosphorylation, no single mutant completely inhibited either AngII- or PMA-induced phosphorylation. Combined mutation of the three PKC consensus sites caused an approximately 70% reduction in PMA-mediated phosphorylation. The approximately 60% reduction in AngII (1 microM)-induced phosphorylation of this triple mutant and the partial inhibition of wild-type receptor phosphorylation by bisindolylmaleimide, a specific PKC inhibitor, suggest a significant contribution of PKC to agonist-stimulated regulation. The ratio of PKC to total receptor phosphorylation was greatest at low doses of AngII (1 nM), consistent with the idea that PKC phosphorylates and regulates receptor function at low levels of stimulation, whereas phosphorylation by other kinases is more prevalent at high levels of agonist stimulation. To determine if a single PKC site is favoured when the contribution of PKC varies, the phosphorylation of wild-type and mutant receptors was examined over a range of AngII concentrations (0, 1, 10 and 100 nM). At all AngII concentrations, single mutation of Ser(331), Ser(338) or Ser(348) was incapable of completely preventing receptor phosphorylation, suggesting no clear preference for PKC consensus-site utilization. Together, these results indicate a redundancy in PKC phosphorylation of the AT(1A) receptor, whereby all three consensus sites are utilized to some degree following homologous (AngII) and heterologous (PMA) stimulation. The contribution of PKC phosphorylation to receptor regulation is unclear, but multiple PKC phosphorylation of the AT(1A) receptor may allow independent and/or complementary events to occur at the three separate sites of the C-terminus.
Insights
Protein kinase C (PKC) phosphorylates the type 1 angiotensin II receptor (AT(1A)) at multiple C-terminal sites. This study identifies three serine residues (Ser331, Ser338, Ser348) involved in PKC-mediated phosphorylation, revealing redundancy in receptor regulation.
Area of Science:
- Molecular biology
- Cell signaling
- Biochemistry
Background:
- Protein kinase C (PKC) is known to phosphorylate the type 1 angiotensin II receptor (AT(1A)) C-terminus.
- The specific phosphorylation sites and their contribution to AT(1A) receptor regulation remain unidentified.
- Understanding these sites is crucial for elucidating angiotensin II signaling pathways.
Purpose of the Study:
- To identify the specific serine residues in the AT(1A) receptor C-terminus phosphorylated by PKC.
- To investigate the role of these phosphorylation sites in AT(1A) receptor regulation by angiotensin II (AngII) and PKC activators.
- To determine the contribution of PKC phosphorylation to AT(1A) receptor function under varying agonist stimulation levels.
Main Methods:
- Utilized epitope-tagged wild-type and mutant AT(1A) receptors (Ser to Ala substitutions at Ser(331), Ser(338), Ser(348)) expressed in Chinese hamster ovary K1 cells.
- Stimulated receptors with AngII or phorbol ester (PMA) to activate PKC, and used a PKC inhibitor (bisindolylmaleimide).
- Quantified receptor phosphorylation levels using Western blotting and compared phosphorylation in wild-type versus mutant receptors across different AngII concentrations.
Main Results:
- AngII and PMA stimulation increased wild-type AT(1A) receptor phosphorylation, which was abolished by C-terminal truncation.
- Single serine-to-alanine mutations reduced phosphorylation, but no single mutant completely inhibited AngII- or PMA-induced phosphorylation.
- Triple mutation (Ser(331), Ser(338), Ser(348) to Ala) significantly reduced PMA- and AngII-induced phosphorylation, indicating redundancy and multiple PKC sites.
- PKC contributed more to AT(1A) receptor phosphorylation at low AngII concentrations (1 nM), suggesting a role in initial receptor regulation.
- No single PKC consensus site showed preferential utilization across different AngII concentrations.
Conclusions:
- The AT(1A) receptor C-terminus contains at least three redundant PKC phosphorylation sites (Ser(331), Ser(338), Ser(348)).
- PKC plays a significant role in agonist-stimulated AT(1A) receptor regulation, particularly at low AngII concentrations.
- Multiple phosphorylation events at these sites may allow for independent or complementary regulatory functions of the AT(1A) receptor.